From study of contiguous sections of the same Cleveland Clinic colorectal tissue microarray specimen set stained for syndecan-1, we identified that loss of tumor cell syndecan-1 did not correlate with the upregulation of fascin in clinically aggressive adenocarcinomas. Here, FSCN1 is linked to neoplasm.